Exelixis Inc. Stock
€20.31
Your prediction
Exelixis Inc. Stock
Pros and Cons of Exelixis Inc. in the next few years
Pros
Cons
Performance of Exelixis Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Exelixis Inc. | 1.280% | -1.264% | 5.561% | 16.423% | -7.176% | 8.639% | 9.772% |
Ironwood Pharmaceuticals | -2.700% | -9.244% | -6.897% | -46.535% | -47.059% | -42.857% | - |
Novocure Ltd | -8.780% | -9.323% | -10.623% | -55.245% | 26.725% | -90.308% | - |
Iovance Biotherapeutics Inc. | -0.740% | 0.534% | -20.076% | 1.511% | -3.637% | -63.635% | - |
Comments
News
![Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?: https://g.foolcdn.com/editorial/images/776121/physician-talking-to-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMWFXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--99d8196e52f82ce755c490f9294c8fe48441668b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/physician-talking-to-patient.jpg?locale=us)
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Many billionaire investors are going all in on artificial intelligence (AI). That's understandable. AI is quickly being integrated into businesses' day-to-day operations. The leaders in the field
![Exelixis (EXEL) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeSt3V1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9dfca4603c1fc3af5c96a68f8938e1fa8ce6aed8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/featured-transcript-logo-template-2023-01-12.jpg?locale=us)
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q1 2024 Earnings CallApr 30, 2024, 5:00 p.m. ET
Operator
Source Fool.com
![2 Stocks Under $30 to Buy and Hold: https://g.foolcdn.com/editorial/images/765350/doctor-and-patient-in-a-hospital-room.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEUzYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5daea28d9de89001ff39b078fa9e748cf34be696/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/doctor-and-patient-in-a-hospital-room.jpg?locale=us)
2 Stocks Under $30 to Buy and Hold
What is a reasonable sum of money to start investing in stocks? $10,000? $1,000? $500? The truth is, thanks to online brokers who now offer trades at low or no fees and fractional shares, investors